Abstract
The Type 2 precusor plasmacytoid dendritic cells (pDC) represent the most important cell type in antiviral innate immunity. To understand the function of pDC during hepatitis B virus infection, the frequency and function of circulating pDC were analyzed by flow cytometric analysis, and IFN-α secretion of total PBMCs was determined by ELISA assay in 25 healthy subjects and 116 patients at various stages of chronic hepatitis B virus infection (CHB). The number of circulating pDC was found to be significantly lower in patients with CHB and associated liver cirrhosis (LC). The ability of PBMCs to secrete IFN-α also decreased significantly. There was a corresponding decrease of circulating NK cells and CD8+ T cells. We observed that lamuvidine antiviral therapy restored the number of circulating pDC and there was a reversal of pDC frequency with the control of HBV replication in chronic HBV patients, indicating these subjects are unlikely to be totally immunecompromised. The decrease of pDC was found to be related to nosocomial infections in LC patients. Our results suggest that CHB patients probably have a quantitative and qualitative impairment of circulating pDC or NK cells, which may be associated with HBV persistent infection as well as the nosocomial infections that arise in LC patients.
Article PDF
Similar content being viewed by others

Avoid common mistakes on your manuscript.
References
Curry MP, Koziel M: The dynamics of the immune response in acute hepatitis B: New lessons using new techniques. Hepatology 32:1177, 2000
Kao JH, Chen DS: Global control of hepatitis B virus infection. Lancet Infect Dis 2:395, 2002
Jung MC, Pape GR: Immunology of hepatitis B infection. Lancet Infect Dis 2:43, 2002
Wang FS, Xing LH, Liu MX, Zhu CL, Liu HG, Wang HF, Lei ZY: Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 7:537, 2001
Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A, Brown D, Amlot PL, Williams R, Vergani D, Dusheiko GM, Bertoletti A: Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms. Hepatology 32:1117, 2000
Bertoletti A, Ferrari C: Kinetics of the immune response during HBV and HCV infection. Hepatology 38:4, 2003
Chisari FV: Rous-Whipple Award Lecture. Viruses, immunity, and cancer: Lessons from hepatitis B. Am J Pathol 156:1117, 2000
Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65, 2001
Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, King AS, Herberg J, Gilson R, Alisa A, Williams R, Vergani D, Naoumov NV, Ferrari C, Bertoletti A: The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191:1269, 2000
Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13:29, 1995
Shimada N, Yamamoto K, Kuroda MJ, Terada R, Hakoda T, Shimomura H, Hata H, Nakayama E, Shiratori Y: HBcAg-specific CD8 T cells play an important role in virus suppression, and acute flare-up is associated with the expansion of activated memory T cells. J Clin Immunol 23:223, 2003
Jilbert AR, Wu TT, England JM, Hall PM, Carp NZ, O’Connell AP, Mason WS: Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66:1377, 1992
Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV: Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825, 1999
Kadowaki N, Antonenko S, Lau JY, Liu YJ: Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219, 2000
Liu YJ: Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259, 2001
Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 18:767, 2000
Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835, 1999
Liu YJ, Kanzler H, Soumelis V, Gilliet M: Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol 2:585, 2001
Auffermann-Gretzinger S, Keeffe EB, Levy S: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171, 2001
Knight SC, Macatonia SE, Patterson S: Infection of dendritic cells with HIV1: Virus load regulates stimulation and suppression of T-cell activity. Res Virol 144:75, 1993
Engelmayer J, Larsson M, Subklewe M, Chahroudi A, Cox WI, Steinman RM, Bhardwaj N: Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion. J Immunol 163:6762, 1999
Kruse M, Rosorius O, Kratzer F, Stelz G, Kuhnt C, Schuler G, Hauber J, Steinkasserer A: Mature dendritic cells infected with herpes simplex virus type 1 exhibit inhibited T-cell stimulatory capacity. J Virol 74:7127, 2000
Beckebaum S, Cicinnati VR, Dworacki G, Muller-Berghaus J, Stolz D, Harnaha J, Whiteside TL, Thomson AW, Lu L, Fung JJ, Bonham CA: Reduction in the circulating pDC1/pDC ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 104:138, 2002
Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G: Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: Mechanisms for viral immune escape. Immunology 109:487, 2003
Arima S, Akbar SM, Michitaka K, Horiike N, Nuriya H, Kohara M, Onji M: Impaired function of antigen-presenting dendritic cells in patients with chronic hepatitis B: Localization of HBV DNA and HBV RNA in blood DC by in situ hybridization. Int J Mol Med 11:169, 2003
Ninomiya T, Akbar SM, Masumoto T, Horiike N, Onji M: Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 31:323, 1999
Chen S, Akbar SM, Tanimoto K, Ninomiya T, Iuchi H, Michitaka K, Horiike N, Onji M: Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: Relevance to hepatocarcinogenesis. Cancer Lett 148:49, 2000
Feldman S, Stein D, Amrute S, Denny T, Garcia Z, Kloser P, Sun Y, Megjugorac N, Fitzgerald-Bocarsly P: Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin Immunol 101:201, 2001
Soumelis V, Scott I, Gheyas F, Bouhour D, Cozon G, Cotte L, Huang L, Levy JA, Liu YJ: Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 98:906, 2001
Chehimi J, Campbell DE, Azzoni L, Bacheller D, Papasavvas E, Jerandi G, Mounzer K, Kostman J, Trinchieri G, Montaner LJ: Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 168:4796, 2002
Palucka K, Banchereau J: Dendritic cells: A link between innate and adaptive immunity. J Clin Immunol 19:12, 1999
Kelsall BL, Biron CA, Sharma O, Kaye PM: Dendritic cells at the host--pathogen interface. Nat Immunol 3:699, 2002
Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol 9:24, 1997
Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, Urbani S, Scognamiglio P, Boehme R, Panebianco R, Fiaccadori F, Ferrari C: Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 102:968, 1998
Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F: Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 345:258, 1990
Reignat S, Webster GJ, Brown D, Ogg GS, King A, Seneviratne SL, Dusheiko G, Williams R, Maini MK, Bertoletti A: Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 195:1089, 2002
Hoofnagle JH: Therapy of viral hepatitis. Digestion 59:563, 1998
Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, Cavalli A, Urbani S, Boehme R, Panebianco R, Fiaccadori F, Ferrari C: Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy. Hepatology 33:963, 2001
Kakimi K, Lane TE, Chisari FV, Guidotti LG: Cutting edge: Inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 167:6701, 2001
Kakimi K, Guidotti LG, Koezuka Y, Chisari FV: Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192:921, 2000
Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS: Hepatitis B virus genotypes in the United States: Results of a nationwide study. Gastroenterology 125:444, 2003
Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR: Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Am J Gastroenterol 95:2894, 2000
Hall MA, Ahmadi KR, Norman P, Snieder H, MacGregor AJ, Vaughan RW, Spector TD, Lanchbury JS: Genetic influence on peripheral blood T lymphocyte levels. Genes Immun 1:423, 2000
Hilleman MR: Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications. Vaccine 19:1837, 2001
Shodell M, Siegal EP: Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 56:518, 2002
Teig N, Moses D, Gieseler S, Schauer U: Age-related changes in human blood dendritic cells subpopulations. Scand J Immunol 55:453, 2002
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
DUAN, XZ., WANG, M., LI, HW. et al. Decreased Frequency and Function of Circulating Plasmocytoid Dendritic Cells (pDC) in Hepatitis B Virus Infected Humans. J Clin Immunol 24, 637–646 (2004). https://doi.org/10.1007/s10875-004-6249-y
Issue Date:
DOI: https://doi.org/10.1007/s10875-004-6249-y